[76Br]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice.

[1]  R. Finn,et al.  Radiosynthesis and quality assurance of 5-[124I]Iodo-2'-deoxyuridine for functional PET imaging of cell proliferation. , 1998, Nuclear medicine and biology.

[2]  H. Thierens,et al.  [Methyl-carbon-11] thymidine for in vivo measurement of cell proliferation. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  S. Adelstein,et al.  Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation. , 1996, Journal of Nuclear Medicine.

[4]  S. Adelstein,et al.  Preclinical animal studies with radioiododeoxyuridine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  M G Stabin,et al.  MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  D. Mankoff,et al.  Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  A. Shields,et al.  Development of labeled thymidine analogs for imaging tumor proliferation. , 1996, Nuclear medicine and biology.

[8]  P. Goethals,et al.  Measurement of [methyl-carbon-11]thymidine and its metabolites in head and neck tumors. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  F Daghighian,et al.  Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  J. Baranowska-Kortylewicz,et al.  Radiolabeling kit/generator for 5‐radiohalogenated uridines , 1994 .

[11]  T. Borght,et al.  Brain tumor imaging with PET and 2-[carbon-11]thymidine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  W. Lodewyckx,et al.  Radioiodination of 2'-deoxyuridine: preparation and preliminary evaluation in tumour-bearing rats. , 1994, Applied Radiation and Isotopes.

[13]  A. D. Van den Abbeele,et al.  Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  R. Blasberg,et al.  Iododeoxyuridine uptake and retention as a measure of tumor growth. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  C. Mcginn,et al.  The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation. , 1992, Seminars in oncology.

[16]  T. Lawrence,et al.  The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer. , 1992, Cancer research.

[17]  E. Glatstein,et al.  Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine. , 1992, BJR supplement.

[18]  S. Pauwels,et al.  Noninvasive measurement of liver regeneration with positron emission tomography and [2-11C]thymidine. , 1991, Gastroenterology.

[19]  E. Newlands,et al.  In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man. , 1991, British Journal of Cancer.

[20]  J Grierson,et al.  Utilization of labeled thymidine in DNA synthesis: studies for PET. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  P. Martiat,et al.  In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  A. Shields,et al.  Cellular sources of thymidine nucleotides: studies for PET. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  S. Qaim.  Recent developments in the production of 18F, 75,76,77Br and 123I , 1986 .

[24]  B. Maziére,et al.  Radiopharmaceuticals labelled with bromine isotopes. , 1986, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[25]  J. Gray,et al.  Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Gratzner,et al.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. , 1982, Science.

[27]  J. Veenboer,et al.  76Br and 77Br from decay of cyclotron produced 76Kr and 77Kr , 1979 .

[28]  M. Welch,et al.  EXCITATION FUNCTIONS FOR THE PRODUCTION OF 76Kr AND 77Kr , 1979 .

[29]  G. A. Brinkman,et al.  Excitations functions for the production of 76Kr and 77Kr , 1979 .

[30]  B. Långström,et al.  Simple production of 77Br− and 123I− and their use in the labelling of [77Br]BrUdR and [123I]IUdR , 1979 .

[31]  G. Stöcklin.  Bromine-77 and iodine-123 radiopharmaceuticals. , 1977, The International journal of applied radiation and isotopes.

[32]  H. Ache,et al.  On the preparation of 80Br- or 82Br-biomolecules via excitation labelling methods. , 1976, The International journal of applied radiation and isotopes.

[33]  L. Feinendegen,et al.  Incorporation of thymidine and iododeoxyuridine into the DNA of mouse tissues. , 1975, Canadian journal of physiology and pharmacology.

[34]  A. Wolf,et al.  Detection of DNA synthesis in intact organisms with positron-emitting (methyl- 11 C)thymidine. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Bond,et al.  The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidine in man. , 1963, Cancer research.

[36]  J. Kriss,et al.  The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat. , 1962, Cancer research.

[37]  M. L. Eidinoff,et al.  Administration of 5-iododeoxyuridine-I-131 in the mouse and rat. , 1961, Cancer research.